Integral Diagnostics Limited
ITGDF
$1.00
-$1.06-51.41%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 119.90M | 117.41M | 82.39M | 84.72M | 78.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 119.90M | 117.41M | 82.39M | 84.72M | 78.57M |
| Cost of Revenue | 82.07M | 80.36M | 57.02M | 58.63M | 52.97M |
| Gross Profit | 37.84M | 37.05M | 25.37M | 26.08M | 25.59M |
| SG&A Expenses | 6.35M | 6.22M | 4.79M | 4.92M | 4.27M |
| Depreciation & Amortization | 10.57M | 10.35M | 7.66M | 7.88M | 7.91M |
| Other Operating Expenses | 5.01M | 4.91M | 3.56M | 3.67M | 3.16M |
| Total Operating Expenses | 107.87M | 105.63M | 75.75M | 77.89M | 71.05M |
| Operating Income | 12.03M | 11.78M | 6.64M | 6.82M | 7.51M |
| Income Before Tax | 3.61M | 3.53M | 125.40K | 129.00K | 2.84M |
| Income Tax Expenses | 1.94M | 1.90M | 254.50K | 261.70K | 848.40K |
| Earnings from Continuing Operations | 1.67M | 1.64M | -129.00K | -132.70K | 2.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -46.80K | -45.80K | -- | -- | -- |
| Net Income | 1.62M | 1.59M | -129.00K | -132.70K | 2.00M |
| EBIT | 12.03M | 11.78M | 6.64M | 6.82M | 7.51M |
| EBITDA | 16.28M | 15.94M | 11.46M | 11.78M | 10.68M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Normalized Basic EPS | 0.02 | 0.02 | 0.00 | 0.00 | 0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Normalized Diluted EPS | 0.02 | 0.02 | 0.00 | 0.00 | 0.01 |
| Average Basic Shares Outstanding | 365.74M | 365.74M | 247.50M | 247.50M | 233.74M |
| Average Diluted Shares Outstanding | 372.94M | 372.94M | 247.50M | 247.50M | 233.74M |
| Dividend Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Payout Ratio | 154.59% | 154.59% | -1,924.49% | -1,924.49% | 74.05% |